Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged 6- 59 months with cough, difficult breathing and chest indrawing~* Written informed consent from the caretaker~Exclusion Criteria:~* Children with known heart disease~* Children on medication with Zinc supplements~* Children with obstructive air way disease~* Children with active measles~* Known intolerance or allergy to zinc or zinc-containing products

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Months
- Healthy Volunteers: f

Study Arms:
- Zinc (Type: EXPERIMENTAL): Zinc acetate
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).